Teachers Retirement System of The State of Kentucky Decreases Stake in HealthEquity, Inc. (NASDAQ:HQY)

Teachers Retirement System of The State of Kentucky cut its holdings in shares of HealthEquity, Inc. (NASDAQ:HQYFree Report) by 8.0% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 44,552 shares of the company’s stock after selling 3,886 shares during the period. Teachers Retirement System of The State of Kentucky owned 0.05% of HealthEquity worth $3,647,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. International Assets Investment Management LLC purchased a new position in shares of HealthEquity during the second quarter valued at approximately $35,000. Paladin Wealth LLC purchased a new position in shares of HealthEquity during the third quarter valued at approximately $39,000. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of HealthEquity during the second quarter valued at approximately $73,000. GAMMA Investing LLC boosted its position in shares of HealthEquity by 57.8% during the third quarter. GAMMA Investing LLC now owns 939 shares of the company’s stock valued at $77,000 after purchasing an additional 344 shares in the last quarter. Finally, Quarry LP boosted its position in shares of HealthEquity by 418.8% during the third quarter. Quarry LP now owns 1,349 shares of the company’s stock valued at $110,000 after purchasing an additional 1,089 shares in the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

HealthEquity Trading Up 0.7 %

Shares of NASDAQ:HQY opened at $95.62 on Friday. The company has a market cap of $8.29 billion, a P/E ratio of 87.72, a PEG ratio of 1.10 and a beta of 0.55. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 4.10. HealthEquity, Inc. has a 1 year low of $62.10 and a 1 year high of $105.82. The stock’s fifty day moving average price is $94.06 and its 200-day moving average price is $84.19.

Analyst Ratings Changes

Several equities research analysts recently weighed in on HQY shares. Royal Bank of Canada lifted their price target on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research report on Tuesday. Barrington Research lifted their price target on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research report on Monday, December 2nd. Deutsche Bank Aktiengesellschaft lifted their price target on HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a research report on Wednesday, September 4th. Bank of America lifted their price target on HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. Finally, The Goldman Sachs Group began coverage on HealthEquity in a research report on Friday, November 15th. They set a “neutral” rating and a $108.00 price target on the stock. One analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $110.71.

Get Our Latest Research Report on HQY

Insider Activity

In related news, Director Frank Corvino sold 1,247 shares of the company’s stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $80.26, for a total transaction of $100,084.22. Following the completion of the sale, the director now owns 4,823 shares in the company, valued at approximately $387,093.98. This represents a 20.54 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Stuart B. Parker sold 25,000 shares of the company’s stock in a transaction on Thursday, December 12th. The shares were sold at an average price of $96.72, for a total value of $2,418,000.00. Following the sale, the director now owns 19,061 shares of the company’s stock, valued at approximately $1,843,579.92. This trade represents a 56.74 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 43,786 shares of company stock valued at $4,140,387 over the last ninety days. 2.20% of the stock is currently owned by corporate insiders.

About HealthEquity

(Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Recommended Stories

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.